A Model of Care Based on Electronic Patient-Reported Outcomes for the Early Detection and Management of Immune-Related Adverse Events in Patients Under Immunotherapy: A Multicentric Phase II Randomized Controlled Trial (IePRO).

Prof. Dr. rer. Med. Manuela Eicher and Prof. Dr. med. Olivier Michielin have been awarded this “allocated fund for nursing research”, derived from a private donation, starting in November 2018.

News & Events

Posted on

Congratulations to Joëlle Ka Yann Ho, the winner of the ISREC Foundation’s 1st PF Leyvraz Award, promoting interprofessionalism in oncology.

 

Joëlle…

Read more
Posted on

Prof. Mikaël Pittet’s inaugural lecture will take place on Thursday, January 28, 2021 at 12.30 pm. His talk, entitled “Cancer immunotherapy: the next…

Read more
Posted on

The ISREC Foundation is proud to support Prof. Mikaël Pittet’s chair in immuno-oncology at the UNIGE. According to the “Web of Science” ranking, Prof.…

Read more
Posted on

The ISREC Foundation is honored to contribute to the research work in translational oncology performed in the laboratory of Prof. Curzio Rüegg at the…

Read more